Vir en­lists Covid-19 an­ti­body ri­val for can­cer, in­fec­tious dis­ease dis­cov­ery work

Vir — Bob Nelsen and George Scan­gos’ in­fec­tious dis­ease start­up — is go­ing in­to im­muno-on­col­o­gy.

En­list­ing Har­bour Bio­Med as a part­ner, Vir will tap the trans-Pa­cif­ic biotech …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER